
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Silverback Thera
Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.
News
Stock Analysis

last close
$3.47
1-mo return
8.1%
3-mo return
-23.6%
avg daily vol.
326T
52-week high
35.63
52-week low
2.8
market cap.
$118M
forward pe
-
annual div.
-
roe
-28.8%
ltg forecast
-
dividend yield
-
annual rev.
$--
inst own.
83.3%